Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Sophia von Stockum, Kerstin Becker, Anja Bauerfeind, Christian Franke, Franca Fruzzetti, Joaquim Calaf, Christoph Keck & Klaas Heinemann. (2023) NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study. Gynecological Endocrinology 39:1.
Read now
Read now
Sophia von Stockum, Anja Bauerfeind, Kerstin Becker, Christian Franke, Franca Fruzzetti, Joaquim Calaf, Christoph Keck & Klaas Heinemann. (2023) NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study. Gynecological Endocrinology 39:1.
Read now
Read now
Anita L. Nelson. (2023) Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive. Expert Opinion on Pharmacotherapy 24:16, pages 1757-1764.
Read now
Read now
Lara Tiranini, Laura Cucinella, Silvia Martella, David Bosoni, Ellis Martini & Rossella E. Nappi. (2023) Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?. Expert Review of Neurotherapeutics 23:4, pages 377-388.
Read now
Read now
Angelo Cagnacci, Vincenzina Bruni, Costantino Di Carlo & Franca Fruzzetti. (2023) How often is oral contraception used for contraception? The need of benefit’s formalisation. The European Journal of Contraception & Reproductive Health Care 28:2, pages 81-82.
Read now
Read now
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Read now
Kristina Gemzell-Danielsson, Angelo Cagnacci, Nathalie Chabbert-Buffet, Jonathan Douxfils, Jean-Michel Foidart, Ali Kubba, Luis Ignacio Lete Lasa, Diana Mansour, Joseph Neulen, Jaoquim Neves, Fátima Palma, Thomas Römer, Robert Spaczyński & Vera Tóth. (2022) A novel estetrol-containing combined oral contraceptive: European expert panel review. The European Journal of Contraception & Reproductive Health Care 27:5, pages 373-383.
Read now
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2022) Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. The European Journal of Contraception & Reproductive Health Care 27:2, pages 83-84.
Read now
Read now
Tiziana Fidecicchi, Franca Fruzzetti, Luis Ignacio Lete Lasa & Joaquim Calaf. (2022) COVID-19, gender and estroprogestins, what do we know?. The European Journal of Contraception & Reproductive Health Care 27:1, pages 67-74.
Read now
Read now
Articles from other publishers (13)
Dorothea Wunder. (2023) Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis. Praxis 112:4, pages 199-204.
Crossref
Crossref
Laure Morimont, Maud Jost, Ulysse Gaspard, Jean-Michel Foidart, Jean-Michel Dogné & Jonathan Douxfils. (2023) Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone. The Journal of Clinical Endocrinology & Metabolism 108:1, pages 135-143.
Crossref
Crossref
Kathleen McNamee, Alison Edelman, Raymond Hang Wun Li, Simranvir Kaur & Deborah Bateson. (2023) Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence. Seminars in Reproductive Medicine 40:05/06, pages 246-257.
Crossref
Crossref
Annina H. Haverinen, Kaisu M. Luiro, Timea Szanto, Marika H. Kangasniemi, Leena Hiltunen, Susanna Sainio, Terhi T. Piltonen, Riitta Lassila, Juha S. Tapanainen & Oskari Heikinheimo. (2022) Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial. Acta Obstetricia et Gynecologica Scandinavica 101:10, pages 1102-1111.
Crossref
Crossref
Birgit Linnemann, Hannelore Rott, Rainer Zotz & Christina Hart. (2022) Venous Thromboembolism Issues in Women. Hämostaseologie 42:05, pages 290-299.
Crossref
Crossref
Rainer B. Zotz, Christina Hart, Jan Beyer-Westendorf, Hannelore Rott & Birgit Linnemann. (2022) Blutgerinnung und hormonelle KontrazeptivaBlood coagulation and hormonal contraceptives. Gynäkologische Endokrinologie 20:4, pages 263-271.
Crossref
Crossref
David F. Archer, Diana Mansour & Jean-Michel Foidart. (2022) Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview. Journal of Clinical Medicine 11:15, pages 4634.
Crossref
Crossref
I. Lete. (2022) Evolución del estrógeno en la anticoncepción hormonal combinada: del etinilestradiol al estetrol pasando por el estradiol. Clínica e Investigación en Ginecología y Obstetricia 49:3, pages 100755.
Crossref
Crossref
Annina Haverinen, Kaisu Luiro, Marika H Kangasniemi, Terhi T Piltonen, Steinar Hustad, Oskari Heikinheimo & Juha S Tapanainen. (2022) Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis. The Journal of Clinical Endocrinology & Metabolism 107:7, pages e3008-e3017.
Crossref
Crossref
Rossella E. Nappi, Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco & Cristina Tassorelli. (2022) Role of Estrogens in Menstrual Migraine. Cells 11:8, pages 1355.
Crossref
Crossref
Geneviève Plu-Bureau & Brigitte Raccah-Tebeka. (2022) La balance bénéfices-risques des contraceptions hormonales estroprogestatives. médecine/sciences 38:1, pages 59-69.
Crossref
Crossref
Eike Eymers & Thomas Römer. 2022. Arzneimittel-Kompass 2022. Arzneimittel-Kompass 2022
127
137
.
Laure Morimont, Hélène Haguet, Jean-Michel Dogné, Ulysse Gaspard & Jonathan Douxfils. (2021) Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology 12.
Crossref
Crossref